AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021
For the full year, sales was SEK 44.65 million compared to SEK 23.71 million a year ago. Net income was SEK 5.16 million compared to SEK 1.51 million a year ago. Basic earnings per share from continuing operations was SEK 0.08 compared to SEK 0.03 a year ago.